Shandong Boan Biotechnology Co., Ltd.

SEHK:6955 Stock Report

Market Cap: HK$5.1b

Shandong Boan Biotechnology Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Hua Jiang

Chief executive officer

CN¥6.8m

Total compensation

CEO salary percentage43.2%
CEO tenure3.8yrs
CEO ownership1.8%
Management average tenure2.3yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Investor Optimism Abounds Shandong Boan Biotechnology Co., Ltd. (HKG:6955) But Growth Is Lacking

Mar 26
Investor Optimism Abounds Shandong Boan Biotechnology Co., Ltd. (HKG:6955) But Growth Is Lacking

CEO Compensation Analysis

How has Hua Jiang's remuneration changed compared to Shandong Boan Biotechnology's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CN¥119m

Sep 30 2023n/an/a

-CN¥209m

Jun 30 2023n/an/a

-CN¥298m

Mar 31 2023n/an/a

-CN¥315m

Dec 31 2022CN¥7mCN¥3m

-CN¥332m

Sep 30 2022n/an/a

-CN¥291m

Jun 30 2022n/an/a

-CN¥251m

Mar 31 2022n/an/a

-CN¥238m

Dec 31 2021CN¥7mCN¥3m

-CN¥225m

Dec 31 2020CN¥967kCN¥938k

-CN¥241m

Compensation vs Market: Hua's total compensation ($USD934.96K) is above average for companies of similar size in the Hong Kong market ($USD492.09K).

Compensation vs Earnings: Hua's compensation has been consistent with company performance over the past year.


CEO

Hua Jiang (45 yo)

3.8yrs

Tenure

CN¥6,775,000

Compensation

Ms. Hua Jiang has been an Executive Director at Shandong Boan Biotechnology Co., Ltd. since March 25, 2022. She is the Chairlady and Chief Executive Officer at Shandong Boan Biotechnology Co., Ltd.She ser...


Leadership Team

NamePositionTenureCompensationOwnership
Hua Jiang
Executive Chairlady & CEOno dataCN¥6.78m1.77%
CN¥ 90.0m
Changlin Dou
COO, President of R&D and Executive Directorno dataCN¥7.33m1.34%
CN¥ 68.0m
Shenghan Wang
Chief Financial Officer3.6yrsno datano data
Jun Lu
Senior VP and Head of Biotechnology Engineering Center & Quality Department3.3yrsno datano data
Deyong Song
Head of Biologics Discovery Department2.3yrsno datano data
Chunna You
Senior Vice President of R&D Centerno datano datano data
Zhou Ming
Chief Medical Officer1.3yrsno datano data
Siu Kuen Lai
Company Secretary2.1yrsno datano data

2.3yrs

Average Tenure

46yo

Average Age

Experienced Management: 6955's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Hua Jiang
Executive Chairlady & CEO3.8yrsCN¥6.78m1.77%
CN¥ 90.0m
Changlin Dou
COO, President of R&D and Executive Director4.4yrsCN¥7.33m1.34%
CN¥ 68.0m
Jixiong Dai
Independent Non-Executive Director3.1yrsCN¥100.00kno data
Yuan Chong Liu
Non Executive Director3.8yrsCN¥1.55m0.79%
CN¥ 40.0m
Lu Wen Shi
Independent Non-Executive Director3.1yrsCN¥100.00kno data
Li Li
Non Executive Director3.8yrsCN¥1.36mno data
Jialin Yu
Independent Non-Executive Director1.3yrsCN¥8.00kno data
Xia Ning
Supervisor3.1yrsno datano data
Xiaomei Zhang
Chairlady of Supervisory Board3.1yrsno datano data
Xiangjie Liu
Supervisor3.1yrsno datano data

3.1yrs

Average Tenure

52yo

Average Age

Experienced Board: 6955's board of directors are considered experienced (3.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.